Literature DB >> 15113590

Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis.

Yuka Shimada1, Kazuhiko Takehara, Shinichi Sato.   

Abstract

BACKGROUND: Chemokines and their receptors are important elements for the selective attraction and activation of various subsets of leukocytes. Expression of CXCR3 ligands, such as monokine induced by IFN-gamma (Mig) leads to preferential Th1 recruitment, whereas CCR4 ligands, thymus and activation regulated chemokine (TARC) or macrophage derived chemokine (MDC), mediate preferential Th2 recruitment. Although atopic dermatitis (AD) has been shown to be a Th2-type disease, recent studies have revealed that Th1-type cytokines, such as IFN-gamma, especially in chronic skin lesions, play important roles in pathogenesis of AD.
OBJECTIVE: The purpose of this study was to investigate serum levels of Th2 chemokines TARC and MDC and a Th1 chemokine Mig in the same samples from patients with AD and their clinical correlation.
METHODS: Serum chemokine levels in patients with AD (n = 55), contact dermatitis (CD; n = 15), and normal controls (n = 30) were examined by ELISA.
RESULTS: Serum levels of TARC and MDC in AD patients and CD patients were significantly higher than those found in normal controls. Serum levels of these chemokines were similar for AD patients and CD patients. Furthermore, these levels correlated positively with disease severity, total IgE levels, and peripheral eosinophilia in AD patients. Serum Mig levels in AD patients and CD patients were significantly higher than those in control subjects. However, serum Mig levels were significantly elevated in CD patients relative to AD patients. Furthermore, serum Mig levels correlated positively with levels of both TARC and MDC in AD patients.
CONCLUSION: These results suggest that both Th2 and Th1 chemokines may play roles in the development of AD. Copyright 2004 Japanese Society for Investigative Dermatology

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15113590     DOI: 10.1016/j.jdermsci.2004.01.001

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  45 in total

1.  Langerhans cells are critical in epicutaneous sensitization with protein antigen via thymic stromal lymphopoietin receptor signaling.

Authors:  Saeko Nakajima; Botond Z Igyártó; Tetsuya Honda; Gyohei Egawa; Atsushi Otsuka; Mariko Hara-Chikuma; Norihiko Watanabe; Steven F Ziegler; Michio Tomura; Kayo Inaba; Yoshiki Miyachi; Daniel H Kaplan; Kenji Kabashima
Journal:  J Allergy Clin Immunol       Date:  2012-03-03       Impact factor: 10.793

2.  Igalan from Inula helenium (L.) suppresses the atopic dermatitis-like response in stimulated HaCaT keratinocytes via JAK/STAT3 signaling.

Authors:  Thien T P Dao; Kwangho Song; Jee Young Kim; Yeong Shik Kim
Journal:  Inflamm Res       Date:  2020-01-30       Impact factor: 4.575

3.  Stratum Corneum Tape Stripping: Monitoring of Inflammatory Mediators in Atopic Dermatitis Patients Using Topical Therapy.

Authors:  Sjors A Koppes; Richard Brans; Suzana Ljubojevic Hadzavdic; Monique H W Frings-Dresen; Thomas Rustemeyer; Sanja Kezic
Journal:  Int Arch Allergy Immunol       Date:  2016-09-02       Impact factor: 2.749

4.  Requirement of CCL17 for CCR7- and CXCR4-dependent migration of cutaneous dendritic cells.

Authors:  Susanne Stutte; Thomas Quast; Nancy Gerbitzki; Terhi Savinko; Nina Novak; Julia Reifenberger; Bernhard Homey; Waldemar Kolanus; Harri Alenius; Irmgard Förster
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-26       Impact factor: 11.205

5.  Ginsenoside Rg5:Rk1 attenuates TNF-α/IFN-γ-induced production of thymus- and activation-regulated chemokine (TARC/CCL17) and LPS-induced NO production via downregulation of NF-κB/p38 MAPK/STAT1 signaling in human keratinocytes and macrophages.

Authors:  Sungeun Ahn; Muhammad Hanif Siddiqi; Veronica Castro Aceituno; Shakina Yesmin Simu; Jinglou Zhang; Zuly Elizabeth Jimenez Perez; Yu-Jin Kim; Deok-Chun Yang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-12-29       Impact factor: 2.416

6.  Suppression of inflammation by recombinant Salmonella typhimurium harboring CCL22 microRNA.

Authors:  Won Suck Yoon; Seung Rel Ryu; Seung Seok Lee; Yang Seok Chae; Eun Jae Kim; Ji Hyun Choi; Sejin Oh; Se Ho Park; Ji Tae Choung; Young Yoo; Yong Keun Park
Journal:  DNA Cell Biol       Date:  2011-08-08       Impact factor: 3.311

7.  TSLP Directly Interacts with Skin-Homing Th2 Cells Highly Expressing its Receptor to Enhance IL-4 Production in Atopic Dermatitis.

Authors:  Kazuki Tatsuno; Toshiharu Fujiyama; Hayato Yamaguchi; Michihiko Waki; Yoshiki Tokura
Journal:  J Invest Dermatol       Date:  2015-08-19       Impact factor: 8.551

8.  Altered chemokine profile associated with exacerbated autoimmune pathology under conditions of genetic interferon-gamma deficiency.

Authors:  Shao Bo Su; Rafael S Grajewski; Dror Luger; Rajeev K Agarwal; Phyllis B Silver; Jun Tang; Jingsheng Tuo; Chi-Chao Chan; Rachel R Caspi
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-10       Impact factor: 4.799

9.  CCR4 agonists CCL22 and CCL17 are elevated in pediatric OMS sera: rapid and selective down-regulation of CCL22 by ACTH or corticosteroids.

Authors:  Michael R Pranzatelli; Elizabeth D Tate; Nathan R McGee; Jerry A Colliver; Richard M Ransohoff
Journal:  J Clin Immunol       Date:  2013-01-23       Impact factor: 8.317

10.  The imbalance in serum concentration of Th-1- and Th-2-derived chemokines as one of the factors involved in pathogenesis of atopic dermatitis.

Authors:  Joanna Narbutt; Aleksandra Lesiak; Anna Sysa-Jedrzeiowska; Marcin Zakrzewski; Jarosław Bogaczewicz; Iwona Stelmach; Piotr Kuna
Journal:  Mediators Inflamm       Date:  2009-07-22       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.